A randomized clinical trial of intravesical instillation of MMC and combination of MMC and Ara-C in non-muscle invasive bladder cancer

Invasive Bladder Cancer ◽

Re: Effect of Intravesical Instillation of Gemcitabine vs Saline Immediately following Resection of Suspected Low-Grade Non-Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial

The Journal of Urology ◽

10.1097/01.ju.0000553700.73423.cb ◽

2019 ◽

Vol 201 (3) ◽

pp. 442-442

Author(s):

Sam S. Chang

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Tumor Recurrence ◽

Invasive Bladder Cancer ◽

Low Grade ◽

The effect of a neoadjuvant instillation of chemotherapy in the prevention of recurrences of non-muscle invasive bladder cancer. Preliminary results of the PRECAVE prospective, controlled, randomized clinical trial

European Urology ◽

10.1016/s0302-2838(21)01132-5 ◽

2021 ◽

Vol 79 ◽

pp. S1043-S1044

Author(s):

D.M. Carrión Monsalve ◽

J. Gomez Rivas ◽

C.R. Trelles ◽

C. Ballesteros Ruiz ◽

M. Alvarez-Maestro ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Preliminary Results ◽

The benefit of a neoadjuvant instillation of chemotherapy in non-muscle invasive bladder cancer: interim analysis of the PRECAVE randomized clinical trial.

10.37554/en-j.arch.esp.urol-20210704-3511-30 ◽

2021 ◽

Author(s):

Diego Carrión ◽

Juan Gómez Rivas ◽

Cristina Ballesteros Ruiz ◽

Mario Álvarez-Maestro ◽

Emilio Ríos González ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Interim Analysis ◽

Invasive Bladder Cancer ◽

Prospective randomized clinical trial of chemohyperthermia with mitomycin-C prior to transurethral resection of the bladder and its relationship with the rate of early recurrence in non-muscle invasive bladder cancer: Intermediate analysis

European Urology Open Science ◽

10.1016/s2666-1683(20)33373-5 ◽

2020 ◽

Vol 19 ◽

pp. e1175-e1176

Author(s):

C. Garcia Alvarez ◽

A.C. Plata Bello ◽

J. Plata Bello ◽

M.A. Tamayo Jover ◽

T. Concepción Masip

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Mitomycin C ◽

Transurethral Resection ◽

Early Recurrence ◽

Invasive Bladder Cancer ◽

Prospective Randomized Clinical Trial ◽

PD42-12 PROSPECTIVE RANDOMIZED CLINICAL TRIAL OF CHEMOHYPERTHERMIA WITH MITOMYCIN-C PRIOR TO TRANSURETHRAL RESECTION OF THE BLADDER AND ITS RELATIONSHIP WITH THE RATE OF EARLY RECURRENCE IN NON-MUSCLE INVASIVE BLADDER CANCER

The Journal of Urology ◽

10.1097/ju.0000000000000922.12 ◽

2020 ◽

Vol 203 ◽

pp. e831-e832

Author(s):

Ana Plata Bello* ◽

Carlos Garcia Alvarez ◽

Julio Plata Bello ◽

Marco Antonio Tamayo Jover ◽

Tomas Concepcion Masip

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Mitomycin C ◽

Transurethral Resection ◽

Early Recurrence ◽

Invasive Bladder Cancer ◽

Prospective Randomized Clinical Trial ◽

Results of the phase-I open-label clinical trial SAKK 06/14 assessing safety of intravesical instillation of the recombinant BCG VPM1002BC in patients with non-muscle invasive bladder cancer and previous failure to conventional BCG therapy

European Urology Supplements ◽

10.1016/s1569-9056(18)31563-x ◽

2018 ◽

Vol 17 (2) ◽

pp. e1050 ◽

Cited By ~ 5

Author(s):

C. Rentsch ◽

P. Bosshard ◽

G. Mayor ◽

M. Rieken ◽

H. Püschel ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Phase I ◽

Invasive Bladder Cancer ◽

Open Label ◽

Bcg Therapy ◽

Muscle Invasive ◽

Recombinant Bcg

A 2-week Maintenance Regimen of Intravesical Instillation of Bacillus Calmette-Guerin is Safe, Adherent and Effective in Patients with Non-muscle-invasive Bladder Cancer: A Prospective, Multicenter Phase II Clinical Trial

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hys097 ◽

2012 ◽

Vol 42 (9) ◽

pp. 813-819 ◽

Cited By ~ 5

Author(s):

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Multicenter Phase ◽

Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy

OncoImmunology ◽

10.1080/2162402x.2020.1748981 ◽

2020 ◽

Vol 9 (1) ◽

pp. 1748981 ◽

Cited By ~ 3

Author(s):

Cyrill A. Rentsch ◽

Piet Bosshard ◽

Grégoire Mayor ◽

Malte Rieken ◽

Heike Püschel ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Phase I ◽

Invasive Bladder Cancer ◽

Bacillus Calmette Guerin ◽

Open Label ◽

Bcg Therapy ◽

Intravesical MMC and MMC+Ara‐C for non‐muscle invasive bladder cancer: A randomized clinical trial

BJU International ◽

10.1111/bju.15571 ◽

2021 ◽

Author(s):

Yasuyoshi Miyata ◽

Toshifumi Tsurusaki ◽

Yasushi Hayashida ◽

Yuji Imasato ◽

Kosuke Takehara ◽

...

Keyword(s):

Clinical Trial ◽

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Faculty Opinions recommendation of Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.739122585.793581022 ◽

2020 ◽

Author(s):

Otto Hemminki

Keyword(s):

Clinical Trial ◽

Gene Therapy ◽

Bladder Cancer ◽

Invasive Bladder Cancer ◽

Repeat Dose ◽

Open Label ◽